Dimension Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.32M | Hold |
27,922
| – | – | 0.36% | 35 |
|
2025
Q1 | $2.26M | Buy |
27,922
+10,635
| +62% | +$862K | 0.4% | 28 |
|
2024
Q4 | $1.56M | Buy |
17,287
+767
| +5% | +$69.1K | 0.25% | 36 |
|
2024
Q3 | $1.63M | Buy |
16,520
+1,209
| +8% | +$119K | 0.3% | 35 |
|
2024
Q2 | $1.42M | Buy |
15,311
+3,396
| +29% | +$315K | 0.29% | 35 |
|
2024
Q1 | $1.13M | Buy |
11,915
+2,827
| +31% | +$268K | 0.23% | 39 |
|
2023
Q4 | $811K | Hold |
9,088
| – | – | 0.17% | 44 |
|
2023
Q3 | $664K | Hold |
9,088
| – | – | 0.16% | 37 |
|
2023
Q2 | $756K | Hold |
9,088
| – | – | 0.16% | 43 |
|
2023
Q1 | $693K | Hold |
9,088
| – | – | 0.16% | 45 |
|
2022
Q4 | $754K | Sell |
9,088
-11,738
| -56% | -$974K | 0.18% | 45 |
|
2022
Q3 | $1.65M | Sell |
20,826
-3,518
| -14% | -$279K | 0.4% | 31 |
|
2022
Q2 | $1.81M | Buy |
24,344
+3,069
| +14% | +$228K | 0.41% | 29 |
|
2022
Q1 | $1.91M | Buy |
+21,275
| New | +$1.91M | 0.36% | 34 |
|